LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
12.03
-0.02 (-0.17%)
At close: Dec 23, 2025, 4:00 PM EST
12.02
-0.01 (-0.08%)
After-hours: Dec 23, 2025, 4:10 PM EST
LENSAR Market Cap
LENSAR has a market cap or net worth of $143.69 million as of December 23, 2025. Its market cap has increased by 70.41% in one year.
Market Cap
143.69M
Enterprise Value
129.94M
1-Year Change
70.41%
Ranking
Category
Stock Price
$12.03
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $143.69M, an increase of 84.21%. That is a compound annual growth rate of 12.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 143.93M | 38.61% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 956.24B |
| Johnson & Johnson | 500.19B |
| AbbVie | 403.81B |
| UnitedHealth Group | 295.32B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 258.45B |
| Abbott Laboratories | 219.51B |